Antiprotozoal Drugs Market

1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Antiprotozoal Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Amoebic Dysentery
        1.2.3 Antimalarial Drug
        1.2.4 Leishmaniasis & Chagas Disease
    1.3 Market by Application
        1.3.1 Global Antiprotozoal Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Clinic
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Antiprotozoal Drugs Market Perspective (2017-2028)
    2.2 Antiprotozoal Drugs Growth Trends by Region
        2.2.1 Antiprotozoal Drugs Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Antiprotozoal Drugs Historic Market Size by Region (2017-2022)
        2.2.3 Antiprotozoal Drugs Forecasted Market Size by Region (2023-2028)
    2.3 Antiprotozoal Drugs Market Dynamics
        2.3.1 Antiprotozoal Drugs Industry Trends
        2.3.2 Antiprotozoal Drugs Market Drivers
        2.3.3 Antiprotozoal Drugs Market Challenges
        2.3.4 Antiprotozoal Drugs Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Antiprotozoal Drugs Players by Revenue
        3.1.1 Global Top Antiprotozoal Drugs Players by Revenue (2017-2022)
        3.1.2 Global Antiprotozoal Drugs Revenue Market Share by Players (2017-2022)
    3.2 Global Antiprotozoal Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Antiprotozoal Drugs Revenue
    3.4 Global Antiprotozoal Drugs Market Concentration Ratio
        3.4.1 Global Antiprotozoal Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Antiprotozoal Drugs Revenue in 2021
    3.5 Antiprotozoal Drugs Key Players Head office and Area Served
    3.6 Key Players Antiprotozoal Drugs Product Solution and Service
    3.7 Date of Enter into Antiprotozoal Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Antiprotozoal Drugs Breakdown Data by Type
    4.1 Global Antiprotozoal Drugs Historic Market Size by Type (2017-2022)
    4.2 Global Antiprotozoal Drugs Forecasted Market Size by Type (2023-2028)
5 Antiprotozoal Drugs Breakdown Data by Application
    5.1 Global Antiprotozoal Drugs Historic Market Size by Application (2017-2022)
    5.2 Global Antiprotozoal Drugs Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Antiprotozoal Drugs Market Size (2017-2028)
    6.2 North America Antiprotozoal Drugs Market Size by Type
        6.2.1 North America Antiprotozoal Drugs Market Size by Type (2017-2022)
        6.2.2 North America Antiprotozoal Drugs Market Size by Type (2023-2028)
        6.2.3 North America Antiprotozoal Drugs Market Share by Type (2017-2028)
    6.3 North America Antiprotozoal Drugs Market Size by Application
        6.3.1 North America Antiprotozoal Drugs Market Size by Application (2017-2022)
        6.3.2 North America Antiprotozoal Drugs Market Size by Application (2023-2028)
        6.3.3 North America Antiprotozoal Drugs Market Share by Application (2017-2028)
    6.4 North America Antiprotozoal Drugs Market Size by Country
        6.4.1 North America Antiprotozoal Drugs Market Size by Country (2017-2022)
        6.4.2 North America Antiprotozoal Drugs Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Antiprotozoal Drugs Market Size (2017-2028)
    7.2 Europe Antiprotozoal Drugs Market Size by Type
        7.2.1 Europe Antiprotozoal Drugs Market Size by Type (2017-2022)
        7.2.2 Europe Antiprotozoal Drugs Market Size by Type (2023-2028)
        7.2.3 Europe Antiprotozoal Drugs Market Share by Type (2017-2028)
    7.3 Europe Antiprotozoal Drugs Market Size by Application
        7.3.1 Europe Antiprotozoal Drugs Market Size by Application (2017-2022)
        7.3.2 Europe Antiprotozoal Drugs Market Size by Application (2023-2028)
        7.3.3 Europe Antiprotozoal Drugs Market Share by Application (2017-2028)
    7.4 Europe Antiprotozoal Drugs Market Size by Country
        7.4.1 Europe Antiprotozoal Drugs Market Size by Country (2017-2022)
        7.4.2 Europe Antiprotozoal Drugs Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Antiprotozoal Drugs Market Size (2017-2028)
    8.2 Asia-Pacific Antiprotozoal Drugs Market Size by Type
        8.2.1 Asia-Pacific Antiprotozoal Drugs Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Antiprotozoal Drugs Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Antiprotozoal Drugs Market Share by Type (2017-2028)
    8.3 Asia-Pacific Antiprotozoal Drugs Market Size by Application
        8.3.1 Asia-Pacific Antiprotozoal Drugs Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Antiprotozoal Drugs Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Antiprotozoal Drugs Market Share by Application (2017-2028)
    8.4 Asia-Pacific Antiprotozoal Drugs Market Size by Region
        8.4.1 Asia-Pacific Antiprotozoal Drugs Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Antiprotozoal Drugs Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Antiprotozoal Drugs Market Size (2017-2028)
    9.2 Latin America Antiprotozoal Drugs Market Size by Type
        9.2.1 Latin America Antiprotozoal Drugs Market Size by Type (2017-2022)
        9.2.2 Latin America Antiprotozoal Drugs Market Size by Type (2023-2028)
        9.2.3 Latin America Antiprotozoal Drugs Market Share by Type (2017-2028)
    9.3 Latin America Antiprotozoal Drugs Market Size by Application
        9.3.1 Latin America Antiprotozoal Drugs Market Size by Application (2017-2022)
        9.3.2 Latin America Antiprotozoal Drugs Market Size by Application (2023-2028)
        9.3.3 Latin America Antiprotozoal Drugs Market Share by Application (2017-2028)
    9.4 Latin America Antiprotozoal Drugs Market Size by Country
        9.4.1 Latin America Antiprotozoal Drugs Market Size by Country (2017-2022)
        9.4.2 Latin America Antiprotozoal Drugs Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Antiprotozoal Drugs Market Size (2017-2028)
    10.2 Middle East & Africa Antiprotozoal Drugs Market Size by Type
        10.2.1 Middle East & Africa Antiprotozoal Drugs Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Antiprotozoal Drugs Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Antiprotozoal Drugs Market Share by Type (2017-2028)
    10.3 Middle East & Africa Antiprotozoal Drugs Market Size by Application
        10.3.1 Middle East & Africa Antiprotozoal Drugs Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Antiprotozoal Drugs Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Antiprotozoal Drugs Market Share by Application (2017-2028)
    10.4 Middle East & Africa Antiprotozoal Drugs Market Size by Country
        10.4.1 Middle East & Africa Antiprotozoal Drugs Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Antiprotozoal Drugs Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Sanofi
        11.1.1 Sanofi Company Details
        11.1.2 Sanofi Business Overview
        11.1.3 Sanofi Antiprotozoal Drugs Introduction
        11.1.4 Sanofi Revenue in Antiprotozoal Drugs Business (2017-2022)
        11.1.5 Sanofi Recent Developments
    11.2 Akthelia Pharmaceuticals Ltd
        11.2.1 Akthelia Pharmaceuticals Ltd Company Details
        11.2.2 Akthelia Pharmaceuticals Ltd Business Overview
        11.2.3 Akthelia Pharmaceuticals Ltd Antiprotozoal Drugs Introduction
        11.2.4 Akthelia Pharmaceuticals Ltd Revenue in Antiprotozoal Drugs Business (2017-2022)
        11.2.5 Akthelia Pharmaceuticals Ltd Recent Developments
    11.3 GlaxoSmithKline Plc
        11.3.1 GlaxoSmithKline Plc Company Details
        11.3.2 GlaxoSmithKline Plc Business Overview
        11.3.3 GlaxoSmithKline Plc Antiprotozoal Drugs Introduction
        11.3.4 GlaxoSmithKline Plc Revenue in Antiprotozoal Drugs Business (2017-2022)
        11.3.5 GlaxoSmithKline Plc Recent Developments
    11.4 Immuron Ltd
        11.4.1 Immuron Ltd Company Details
        11.4.2 Immuron Ltd Business Overview
        11.4.3 Immuron Ltd Antiprotozoal Drugs Introduction
        11.4.4 Immuron Ltd Revenue in Antiprotozoal Drugs Business (2017-2022)
        11.4.5 Immuron Ltd Recent Developments
    11.5 Microbiotix Inc
        11.5.1 Microbiotix Inc Company Details
        11.5.2 Microbiotix Inc Business Overview
        11.5.3 Microbiotix Inc Antiprotozoal Drugs Introduction
        11.5.4 Microbiotix Inc Revenue in Antiprotozoal Drugs Business (2017-2022)
        11.5.5 Microbiotix Inc Recent Developments
    11.6 Protein Potential LLC
        11.6.1 Protein Potential LLC Company Details
        11.6.2 Protein Potential LLC Business Overview
        11.6.3 Protein Potential LLC Antiprotozoal Drugs Introduction
        11.6.4 Protein Potential LLC Revenue in Antiprotozoal Drugs Business (2017-2022)
        11.6.5 Protein Potential LLC Recent Developments
    11.7 Dr. Reddy’s Laboratories
        11.7.1 Dr. Reddy’s Laboratories Company Details
        11.7.2 Dr. Reddy’s Laboratories Business Overview
        11.7.3 Dr. Reddy’s Laboratories Antiprotozoal Drugs Introduction
        11.7.4 Dr. Reddy’s Laboratories Revenue in Antiprotozoal Drugs Business (2017-2022)
        11.7.5 Dr. Reddy’s Laboratories Recent Developments
    11.8 Mission Pharmacal
        11.8.1 Mission Pharmacal Company Details
        11.8.2 Mission Pharmacal Business Overview
        11.8.3 Mission Pharmacal Antiprotozoal Drugs Introduction
        11.8.4 Mission Pharmacal Revenue in Antiprotozoal Drugs Business (2017-2022)
        11.8.5 Mission Pharmacal Recent Developments
    11.9 Aceto Corp.
        11.9.1 Aceto Corp. Company Details
        11.9.2 Aceto Corp. Business Overview
        11.9.3 Aceto Corp. Antiprotozoal Drugs Introduction
        11.9.4 Aceto Corp. Revenue in Antiprotozoal Drugs Business (2017-2022)
        11.9.5 Aceto Corp. Recent Developments
    11.10 Mylan Pharmaceuticals
        11.10.1 Mylan Pharmaceuticals Company Details
        11.10.2 Mylan Pharmaceuticals Business Overview
        11.10.3 Mylan Pharmaceuticals Antiprotozoal Drugs Introduction
        11.10.4 Mylan Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2017-2022)
        11.10.5 Mylan Pharmaceuticals Recent Developments
    11.11 Impax Laboratories
        11.11.1 Impax Laboratories Company Details
        11.11.2 Impax Laboratories Business Overview
        11.11.3 Impax Laboratories Antiprotozoal Drugs Introduction
        11.11.4 Impax Laboratories Revenue in Antiprotozoal Drugs Business (2017-2022)
        11.11.5 Impax Laboratories Recent Developments
    11.12 Pfizer
        11.12.1 Pfizer Company Details
        11.12.2 Pfizer Business Overview
        11.12.3 Pfizer Antiprotozoal Drugs Introduction
        11.12.4 Pfizer Revenue in Antiprotozoal Drugs Business (2017-2022)
        11.12.5 Pfizer Recent Developments
    11.13 Lupin Pharmaceuticals
        11.13.1 Lupin Pharmaceuticals Company Details
        11.13.2 Lupin Pharmaceuticals Business Overview
        11.13.3 Lupin Pharmaceuticals Antiprotozoal Drugs Introduction
        11.13.4 Lupin Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2017-2022)
        11.13.5 Lupin Pharmaceuticals Recent Developments
    11.14 Glenmark Pharmaceuticals
        11.14.1 Glenmark Pharmaceuticals Company Details
        11.14.2 Glenmark Pharmaceuticals Business Overview
        11.14.3 Glenmark Pharmaceuticals Antiprotozoal Drugs Introduction
        11.14.4 Glenmark Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2017-2022)
        11.14.5 Glenmark Pharmaceuticals Recent Developments
    11.15 Sun Pharmaceutical
        11.15.1 Sun Pharmaceutical Company Details
        11.15.2 Sun Pharmaceutical Business Overview
        11.15.3 Sun Pharmaceutical Antiprotozoal Drugs Introduction
        11.15.4 Sun Pharmaceutical Revenue in Antiprotozoal Drugs Business (2017-2022)
        11.15.5 Sun Pharmaceutical Recent Developments
    11.16 Heritage Pharmaceuticals
        11.16.1 Heritage Pharmaceuticals Company Details
        11.16.2 Heritage Pharmaceuticals Business Overview
        11.16.3 Heritage Pharmaceuticals Antiprotozoal Drugs Introduction
        11.16.4 Heritage Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2017-2022)
        11.16.5 Heritage Pharmaceuticals Recent Developments
    11.17 Gilead Sciences
        11.17.1 Gilead Sciences Company Details
        11.17.2 Gilead Sciences Business Overview
        11.17.3 Gilead Sciences Antiprotozoal Drugs Introduction
        11.17.4 Gilead Sciences Revenue in Antiprotozoal Drugs Business (2017-2022)
        11.17.5 Gilead Sciences Recent Developments
    11.18 Johnson & Johnson
        11.18.1 Johnson & Johnson Company Details
        11.18.2 Johnson & Johnson Business Overview
        11.18.3 Johnson & Johnson Antiprotozoal Drugs Introduction
        11.18.4 Johnson & Johnson Revenue in Antiprotozoal Drugs Business (2017-2022)
        11.18.5 Johnson & Johnson Recent Developments
    11.19 Bristol-Myers Squibb
        11.19.1 Bristol-Myers Squibb Company Details
        11.19.2 Bristol-Myers Squibb Business Overview
        11.19.3 Bristol-Myers Squibb Antiprotozoal Drugs Introduction
        11.19.4 Bristol-Myers Squibb Revenue in Antiprotozoal Drugs Business (2017-2022)
        11.19.5 Bristol-Myers Squibb Recent Developments
    11.20 Profounda
        11.20.1 Profounda Company Details
        11.20.2 Profounda Business Overview
        11.20.3 Profounda Antiprotozoal Drugs Introduction
        11.20.4 Profounda Revenue in Antiprotozoal Drugs Business (2017-2022)
        11.20.5 Profounda Recent Developments
    11.21 Knight Therapeutics
        11.21.1 Knight Therapeutics Company Details
        11.21.2 Knight Therapeutics Business Overview
        11.21.3 Knight Therapeutics Antiprotozoal Drugs Introduction
        11.21.4 Knight Therapeutics Revenue in Antiprotozoal Drugs Business (2017-2022)
        11.21.5 Knight Therapeutics Recent Developments
    11.22 Albert David
        11.22.1 Albert David Company Details
        11.22.2 Albert David Business Overview
        11.22.3 Albert David Antiprotozoal Drugs Introduction
        11.22.4 Albert David Revenue in Antiprotozoal Drugs Business (2017-2022)
        11.22.5 Albert David Recent Developments
    11.23 Wanlong
        11.23.1 Wanlong Company Details
        11.23.2 Wanlong Business Overview
        11.23.3 Wanlong Antiprotozoal Drugs Introduction
        11.23.4 Wanlong Revenue in Antiprotozoal Drugs Business (2017-2022)
        11.23.5 Wanlong Recent Developments
    11.24 Fangsheng
        11.24.1 Fangsheng Company Details
        11.24.2 Fangsheng Business Overview
        11.24.3 Fangsheng Antiprotozoal Drugs Introduction
        11.24.4 Fangsheng Revenue in Antiprotozoal Drugs Business (2017-2022)
        11.24.5 Fangsheng Recent Developments
    11.25 KPC Pharmaceuticals
        11.25.1 KPC Pharmaceuticals Company Details
        11.25.2 KPC Pharmaceuticals Business Overview
        11.25.3 KPC Pharmaceuticals Antiprotozoal Drugs Introduction
        11.25.4 KPC Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2017-2022)
        11.25.5 KPC Pharmaceuticals Recent Developments
    11.26 Guilin Pharmaceuticals
        11.26.1 Guilin Pharmaceuticals Company Details
        11.26.2 Guilin Pharmaceuticals Business Overview
        11.26.3 Guilin Pharmaceuticals Antiprotozoal Drugs Introduction
        11.26.4 Guilin Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2017-2022)
        11.26.5 Guilin Pharmaceuticals Recent Developments
    11.27 Pude Pharmaceutica
        11.27.1 Pude Pharmaceutica Company Details
        11.27.2 Pude Pharmaceutica Business Overview
        11.27.3 Pude Pharmaceutica Antiprotozoal Drugs Introduction
        11.27.4 Pude Pharmaceutica Revenue in Antiprotozoal Drugs Business (2017-2022)
        11.27.5 Pude Pharmaceutica Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
List of Tables
    Table 1. Global Antiprotozoal Drugs Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Amoebic Dysentery
    Table 3. Key Players of Antimalarial Drug
    Table 4. Key Players of Leishmaniasis & Chagas Disease
    Table 5. Global Antiprotozoal Drugs Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 6. Global Antiprotozoal Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Antiprotozoal Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Antiprotozoal Drugs Market Share by Region (2017-2022)
    Table 9. Global Antiprotozoal Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Antiprotozoal Drugs Market Share by Region (2023-2028)
    Table 11. Antiprotozoal Drugs Market Trends
    Table 12. Antiprotozoal Drugs Market Drivers
    Table 13. Antiprotozoal Drugs Market Challenges
    Table 14. Antiprotozoal Drugs Market Restraints
    Table 15. Global Antiprotozoal Drugs Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Antiprotozoal Drugs Revenue Share by Players (2017-2022)
    Table 17. Global Top Antiprotozoal Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiprotozoal Drugs as of 2021)
    Table 18. Ranking of Global Top Antiprotozoal Drugs Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Antiprotozoal Drugs Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Antiprotozoal Drugs Product Solution and Service
    Table 22. Date of Enter into Antiprotozoal Drugs Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Antiprotozoal Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Antiprotozoal Drugs Revenue Market Share by Type (2017-2022)
    Table 26. Global Antiprotozoal Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Antiprotozoal Drugs Revenue Market Share by Type (2023-2028)
    Table 28. Global Antiprotozoal Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Antiprotozoal Drugs Revenue Share by Application (2017-2022)
    Table 30. Global Antiprotozoal Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Antiprotozoal Drugs Revenue Share by Application (2023-2028)
    Table 32. North America Antiprotozoal Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 33. North America Antiprotozoal Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 34. North America Antiprotozoal Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 35. North America Antiprotozoal Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 36. North America Antiprotozoal Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 37. North America Antiprotozoal Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Europe Antiprotozoal Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 39. Europe Antiprotozoal Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 40. Europe Antiprotozoal Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 41. Europe Antiprotozoal Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 42. Europe Antiprotozoal Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Europe Antiprotozoal Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Asia Pacific Antiprotozoal Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 45. Asia Pacific Antiprotozoal Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Antiprotozoal Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Antiprotozoal Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Antiprotozoal Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Antiprotozoal Drugs Market Size by Region (2023-2028) & (US$ Million)
    Table 50. Latin America Antiprotozoal Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 51. Latin America Antiprotozoal Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 52. Latin America Antiprotozoal Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 53. Latin America Antiprotozoal Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 54. Latin America Antiprotozoal Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 55. Latin America Antiprotozoal Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 56. Middle East and Africa Antiprotozoal Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 57. Middle East and Africa Antiprotozoal Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Antiprotozoal Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Antiprotozoal Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Antiprotozoal Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Antiprotozoal Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 62. Sanofi Company Details
    Table 63. Sanofi Business Overview
    Table 64. Sanofi Antiprotozoal Drugs Product
    Table 65. Sanofi Revenue in Antiprotozoal Drugs Business (2017-2022) & (US$ Million)
    Table 66. Sanofi Recent Developments
    Table 67. Akthelia Pharmaceuticals Ltd Company Details
    Table 68. Akthelia Pharmaceuticals Ltd Business Overview
    Table 69. Akthelia Pharmaceuticals Ltd Antiprotozoal Drugs Product
    Table 70. Akthelia Pharmaceuticals Ltd Revenue in Antiprotozoal Drugs Business (2017-2022) & (US$ Million)
    Table 71. Akthelia Pharmaceuticals Ltd Recent Developments
    Table 72. GlaxoSmithKline Plc Company Details
    Table 73. GlaxoSmithKline Plc Business Overview
    Table 74. GlaxoSmithKline Plc Antiprotozoal Drugs Product
    Table 75. GlaxoSmithKline Plc Revenue in Antiprotozoal Drugs Business (2017-2022) & (US$ Million)
    Table 76. GlaxoSmithKline Plc Recent Developments
    Table 77. Immuron Ltd Company Details
    Table 78. Immuron Ltd Business Overview
    Table 79. Immuron Ltd Antiprotozoal Drugs Product
    Table 80. Immuron Ltd Revenue in Antiprotozoal Drugs Business (2017-2022) & (US$ Million)
    Table 81. Immuron Ltd Recent Developments
    Table 82. Microbiotix Inc Company Details
    Table 83. Microbiotix Inc Business Overview
    Table 84. Microbiotix Inc Antiprotozoal Drugs Product
    Table 85. Microbiotix Inc Revenue in Antiprotozoal Drugs Business (2017-2022) & (US$ Million)
    Table 86. Microbiotix Inc Recent Developments
    Table 87. Protein Potential LLC Company Details
    Table 88. Protein Potential LLC Business Overview
    Table 89. Protein Potential LLC Antiprotozoal Drugs Product
    Table 90. Protein Potential LLC Revenue in Antiprotozoal Drugs Business (2017-2022) & (US$ Million)
    Table 91. Protein Potential LLC Recent Developments
    Table 92. Dr. Reddy’s Laboratories Company Details
    Table 93. Dr. Reddy’s Laboratories Business Overview
    Table 94. Dr. Reddy’s Laboratories Antiprotozoal Drugs Product
    Table 95. Dr. Reddy’s Laboratories Revenue in Antiprotozoal Drugs Business (2017-2022) & (US$ Million)
    Table 96. Dr. Reddy’s Laboratories Recent Developments
    Table 97. Mission Pharmacal Company Details
    Table 98. Mission Pharmacal Business Overview
    Table 99. Mission Pharmacal Antiprotozoal Drugs Product
    Table 100. Mission Pharmacal Revenue in Antiprotozoal Drugs Business (2017-2022) & (US$ Million)
    Table 101. Mission Pharmacal Recent Developments
    Table 102. Aceto Corp. Company Details
    Table 103. Aceto Corp. Business Overview
    Table 104. Aceto Corp. Antiprotozoal Drugs Product
    Table 105. Aceto Corp. Revenue in Antiprotozoal Drugs Business (2017-2022) & (US$ Million)
    Table 106. Aceto Corp. Recent Developments
    Table 107. Mylan Pharmaceuticals Company Details
    Table 108. Mylan Pharmaceuticals Business Overview
    Table 109. Mylan Pharmaceuticals Antiprotozoal Drugs Product
    Table 110. Mylan Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2017-2022) & (US$ Million)
    Table 111. Mylan Pharmaceuticals Recent Developments
    Table 112. Impax Laboratories Company Details
    Table 113. Impax Laboratories Business Overview
    Table 114. Impax Laboratories Antiprotozoal Drugs Product
    Table 115. Impax Laboratories Revenue in Antiprotozoal Drugs Business (2017-2022) & (US$ Million)
    Table 116. Impax Laboratories Recent Developments
    Table 117. Pfizer Company Details
    Table 118. Pfizer Business Overview
    Table 119. Pfizer Antiprotozoal Drugs Product
    Table 120. Pfizer Revenue in Antiprotozoal Drugs Business (2017-2022) & (US$ Million)
    Table 121. Pfizer Recent Developments
    Table 122. Lupin Pharmaceuticals Company Details
    Table 123. Lupin Pharmaceuticals Business Overview
    Table 124. Lupin Pharmaceuticals Antiprotozoal Drugs Product
    Table 125. Lupin Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2017-2022) & (US$ Million)
    Table 126. Lupin Pharmaceuticals Recent Developments
    Table 127. Glenmark Pharmaceuticals Company Details
    Table 128. Glenmark Pharmaceuticals Business Overview
    Table 129. Glenmark Pharmaceuticals Antiprotozoal Drugs Product
    Table 130. Glenmark Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2017-2022) & (US$ Million)
    Table 131. Glenmark Pharmaceuticals Recent Developments
    Table 132. Sun Pharmaceutical Company Details
    Table 133. Sun Pharmaceutical Business Overview
    Table 134. Sun Pharmaceutical Antiprotozoal Drugs Product
    Table 135. Sun Pharmaceutical Revenue in Antiprotozoal Drugs Business (2017-2022) & (US$ Million)
    Table 136. Sun Pharmaceutical Recent Developments
    Table 137. Heritage Pharmaceuticals Company Details
    Table 138. Heritage Pharmaceuticals Business Overview
    Table 139. Heritage Pharmaceuticals Antiprotozoal Drugs Product
    Table 140. Heritage Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2017-2022) & (US$ Million)
    Table 141. Heritage Pharmaceuticals Recent Developments
    Table 142. Gilead Sciences Company Details
    Table 143. Gilead Sciences Business Overview
    Table 144. Gilead Sciences Antiprotozoal Drugs Product
    Table 145. Gilead Sciences Revenue in Antiprotozoal Drugs Business (2017-2022) & (US$ Million)
    Table 146. Gilead Sciences Recent Developments
    Table 147. Johnson & Johnson Company Details
    Table 148. Johnson & Johnson Business Overview
    Table 149. Johnson & Johnson Antiprotozoal Drugs Product
    Table 150. Johnson & Johnson Revenue in Antiprotozoal Drugs Business (2017-2022) & (US$ Million)
    Table 151. Johnson & Johnson Recent Developments
    Table 152. Bristol-Myers Squibb Company Details
    Table 153. Bristol-Myers Squibb Business Overview
    Table 154. Bristol-Myers Squibb Antiprotozoal Drugs Product
    Table 155. Bristol-Myers Squibb Revenue in Antiprotozoal Drugs Business (2017-2022) & (US$ Million)
    Table 156. Bristol-Myers Squibb Recent Developments
    Table 157. Profounda Company Details
    Table 158. Profounda Business Overview
    Table 159. Profounda Antiprotozoal Drugs Product
    Table 160. Profounda Revenue in Antiprotozoal Drugs Business (2017-2022) & (US$ Million)
    Table 161. Profounda Recent Developments
    Table 162. Knight Therapeutics Company Details
    Table 163. Knight Therapeutics Business Overview
    Table 164. Knight Therapeutics Antiprotozoal Drugs Product
    Table 165. Knight Therapeutics Revenue in Antiprotozoal Drugs Business (2017-2022) & (US$ Million)
    Table 166. Knight Therapeutics Recent Developments
    Table 167. Albert David Company Details
    Table 168. Albert David Business Overview
    Table 169. Albert David Antiprotozoal Drugs Product
    Table 170. Albert David Revenue in Antiprotozoal Drugs Business (2017-2022) & (US$ Million)
    Table 171. Albert David Recent Developments
    Table 172. Wanlong Company Details
    Table 173. Wanlong Business Overview
    Table 174. Wanlong Antiprotozoal Drugs Product
    Table 175. Wanlong Revenue in Antiprotozoal Drugs Business (2017-2022) & (US$ Million)
    Table 176. Wanlong Recent Developments
    Table 177. Fangsheng Company Details
    Table 178. Fangsheng Business Overview
    Table 179. Fangsheng Antiprotozoal Drugs Product
    Table 180. Fangsheng Revenue in Antiprotozoal Drugs Business (2017-2022) & (US$ Million)
    Table 181. Fangsheng Recent Developments
    Table 182. KPC Pharmaceuticals Company Details
    Table 183. KPC Pharmaceuticals Business Overview
    Table 184. KPC Pharmaceuticals Antiprotozoal Drugs Product
    Table 185. KPC Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2017-2022) & (US$ Million)
    Table 186. KPC Pharmaceuticals Recent Developments
    Table 187. Guilin Pharmaceuticals Company Details
    Table 188. Guilin Pharmaceuticals Business Overview
    Table 189. Guilin Pharmaceuticals Antiprotozoal Drugs Product
    Table 190. Guilin Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2017-2022) & (US$ Million)
    Table 191. Guilin Pharmaceuticals Recent Developments
    Table 192. Pude Pharmaceutica Company Details
    Table 193. Pude Pharmaceutica Business Overview
    Table 194. Pude Pharmaceutica Antiprotozoal Drugs Product
    Table 195. Pude Pharmaceutica Revenue in Antiprotozoal Drugs Business (2017-2022) & (US$ Million)
    Table 196. Pude Pharmaceutica Recent Developments
    Table 197. Research Programs/Design for This Report
    Table 198. Key Data Information from Secondary Sources
    Table 199. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Antiprotozoal Drugs Market Share by Type: 2021 VS 2028
    Figure 2. Amoebic Dysentery Features
    Figure 3. Antimalarial Drug Features
    Figure 4. Leishmaniasis & Chagas Disease Features
    Figure 5. Global Antiprotozoal Drugs Market Share by Application: 2021 VS 2028
    Figure 6. Hospital Case Studies
    Figure 7. Clinic Case Studies
    Figure 8. Antiprotozoal Drugs Report Years Considered
    Figure 9. Global Antiprotozoal Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Antiprotozoal Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Antiprotozoal Drugs Market Share by Region: 2021 VS 2028
    Figure 12. Global Antiprotozoal Drugs Market Share by Players in 2021
    Figure 13. Global Top Antiprotozoal Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiprotozoal Drugs as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Antiprotozoal Drugs Revenue in 2021
    Figure 15. North America Antiprotozoal Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 16. North America Antiprotozoal Drugs Market Size Market Share by Type (2017-2028)
    Figure 17. North America Antiprotozoal Drugs Market Size Market Share by Application (2017-2028)
    Figure 18. North America Antiprotozoal Drugs Market Size Share by Country (2017-2028)
    Figure 19. United States Antiprotozoal Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Antiprotozoal Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Antiprotozoal Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Antiprotozoal Drugs Market Size Market Share by Type (2017-2028)
    Figure 23. Europe Antiprotozoal Drugs Market Size Market Share by Application (2017-2028)
    Figure 24. Europe Antiprotozoal Drugs Market Size Share by Country (2017-2028)
    Figure 25. Germany Antiprotozoal Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France Antiprotozoal Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. Antiprotozoal Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy Antiprotozoal Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia Antiprotozoal Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries Antiprotozoal Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Antiprotozoal Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 32. Asia Pacific Antiprotozoal Drugs Market Size Market Share by Type (2017-2028)
    Figure 33. Asia Pacific Antiprotozoal Drugs Market Size Market Share by Application (2017-2028)
    Figure 34. Asia Pacific Antiprotozoal Drugs Market Size Share by Region (2017-2028)
    Figure 35. China Antiprotozoal Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Japan Antiprotozoal Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. South Korea Antiprotozoal Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Southeast Asia Antiprotozoal Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. India Antiprotozoal Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Australia Antiprotozoal Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 41. Latin America Antiprotozoal Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 42. Latin America Antiprotozoal Drugs Market Size Market Share by Type (2017-2028)
    Figure 43. Latin America Antiprotozoal Drugs Market Size Market Share by Application (2017-2028)
    Figure 44. Latin America Antiprotozoal Drugs Market Size Share by Country (2017-2028)
    Figure 45. Mexico Antiprotozoal Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Brazil Antiprotozoal Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Middle East & Africa Antiprotozoal Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 48. Middle East and Africa Antiprotozoal Drugs Market Size Market Share by Type (2017-2028)
    Figure 49. Middle East and Africa Antiprotozoal Drugs Market Size Market Share by Application (2017-2028)
    Figure 50. Middle East and Africa Antiprotozoal Drugs Market Size Share by Country (2017-2028)
    Figure 51. Turkey Antiprotozoal Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia Antiprotozoal Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. UAE Antiprotozoal Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Sanofi Revenue Growth Rate in Antiprotozoal Drugs Business (2017-2022)
    Figure 55. Akthelia Pharmaceuticals Ltd Revenue Growth Rate in Antiprotozoal Drugs Business (2017-2022)
    Figure 56. GlaxoSmithKline Plc Revenue Growth Rate in Antiprotozoal Drugs Business (2017-2022)
    Figure 57. Immuron Ltd Revenue Growth Rate in Antiprotozoal Drugs Business (2017-2022)
    Figure 58. Microbiotix Inc Revenue Growth Rate in Antiprotozoal Drugs Business (2017-2022)
    Figure 59. Protein Potential LLC Revenue Growth Rate in Antiprotozoal Drugs Business (2017-2022)
    Figure 60. Dr. Reddy’s Laboratories Revenue Growth Rate in Antiprotozoal Drugs Business (2017-2022)
    Figure 61. Mission Pharmacal Revenue Growth Rate in Antiprotozoal Drugs Business (2017-2022)
    Figure 62. Aceto Corp. Revenue Growth Rate in Antiprotozoal Drugs Business (2017-2022)
    Figure 63. Mylan Pharmaceuticals Revenue Growth Rate in Antiprotozoal Drugs Business (2017-2022)
    Figure 64. Impax Laboratories Revenue Growth Rate in Antiprotozoal Drugs Business (2017-2022)
    Figure 65. Pfizer Revenue Growth Rate in Antiprotozoal Drugs Business (2017-2022)
    Figure 66. Lupin Pharmaceuticals Revenue Growth Rate in Antiprotozoal Drugs Business (2017-2022)
    Figure 67. Glenmark Pharmaceuticals Revenue Growth Rate in Antiprotozoal Drugs Business (2017-2022)
    Figure 68. Sun Pharmaceutical Revenue Growth Rate in Antiprotozoal Drugs Business (2017-2022)
    Figure 69. Heritage Pharmaceuticals Revenue Growth Rate in Antiprotozoal Drugs Business (2017-2022)
    Figure 70. Gilead Sciences Revenue Growth Rate in Antiprotozoal Drugs Business (2017-2022)
    Figure 71. Johnson & Johnson Revenue Growth Rate in Antiprotozoal Drugs Business (2017-2022)
    Figure 72. Bristol-Myers Squibb Revenue Growth Rate in Antiprotozoal Drugs Business (2017-2022)
    Figure 73. Profounda Revenue Growth Rate in Antiprotozoal Drugs Business (2017-2022)
    Figure 74. Knight Therapeutics Revenue Growth Rate in Antiprotozoal Drugs Business (2017-2022)
    Figure 75. Albert David Revenue Growth Rate in Antiprotozoal Drugs Business (2017-2022)
    Figure 76. Wanlong Revenue Growth Rate in Antiprotozoal Drugs Business (2017-2022)
    Figure 77. Fangsheng Revenue Growth Rate in Antiprotozoal Drugs Business (2017-2022)
    Figure 78. KPC Pharmaceuticals Revenue Growth Rate in Antiprotozoal Drugs Business (2017-2022)
    Figure 79. Guilin Pharmaceuticals Revenue Growth Rate in Antiprotozoal Drugs Business (2017-2022)
    Figure 80. Pude Pharmaceutica Revenue Growth Rate in Antiprotozoal Drugs Business (2017-2022)
    Figure 81. Bottom-up and Top-down Approaches for This Report
    Figure 82. Data Triangulation
    Figure 83. Key Executives Interviewed